Norge -
norska -
Statens legemiddelverk
efexor depot 150 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
Norge -
norska -
Statens legemiddelverk
efexor depot 75 mg
upjohn eesv - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
Norge -
norska -
Statens legemiddelverk
venorion 75 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 75 mg
Norge -
norska -
Statens legemiddelverk
venorion 37.5 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 37.5 mg
Norge -
norska -
Statens legemiddelverk
venorion 150 mg
orion corporation - espoo - venlafaksinhydroklorid - depotkapsel, hard - 150 mg
Norge -
norska -
Statens legemiddelverk
fluoxetin viatris 20 mg
viatris limited - fluoksetinhydroklorid - kapsel, hard - 20 mg
Norge -
norska -
Statens legemiddelverk
fenylefrin unimedic 0.05 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.05 mg/ ml
Norge -
norska -
Statens legemiddelverk
fenylefrin unimedic 0.1 mg/ ml
unimedic pharma ab - fenylefrinhydroklorid - injeksjonsvæske, oppløsning - 0.1 mg/ ml
Europeiska unionen -
norska -
EMA (European Medicines Agency)
brintellix
h. lundbeck a/s - vortioxetine - depressiv lidelse, major - psychoanaleptics, - behandling av alvorlige depressive episoder hos voksne.
Europeiska unionen -
norska -
EMA (European Medicines Agency)
xalkori
pfizer europe ma eeig - crizotinib - karsinom, ikke-småcellet lunge - antineoplastiske midler - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.